ImplaStation received FDA 510(k) market clearance!

ImplaStation featuring implant planning and surgical guide design received FDA 510(k) market clearance!.

Prodigident is proud to announce that on December 3, 2021, the FDA (U.S. Food and Drug Administration) granted (510k) market clearance for the sale of the ImplaStation software in the United States.

TO ALL EVENTS

Cases & Articles

Quad-Zygoma as a Solution for Full-Arch Re-treatment: A Functional Approach to Peri-Implantitis

Combining Techniques in Severe Maxillary Atrophy: A Case Study on Tilted and Zygomatic Implants

Revolutionizing All-on-4 Surgery with Stackable Guides and Flapless Techniques

Full-Mouth Implant Placement with Digital Planning: A Clinical Case Study

Hybrid Implant Strategy for Oro-Nasal Communication: 2-Year Follow-Up

Full-Arch Re-Treatment: Applying Hybrid Implant Configurations for Optimal Outcomes